Hypokalaemic periodic paralysis (Hypo-PP) is characterised by transient attacks of muscle weakness of varying duration and severity accompanied by a drop in serum potassium concentration during the attacks. The largest known HypoPP family is ofDutch origin and consists of277 members in the last five generations, 55 ofwhom have HypoPP inherited in an autosomal dominant pattern. Forty-eight persons including 28 patients with a proven diagnosis of HypoPP were used for linkage analysis. Microsatellite markers were used to exclude 45 to 50% of the genome and linkage to chromosome 1q31-32 was found. No recombinants were found between Hy-poPP and DlS412 and a microsatellite contained within the DHP receptor al subunit (CACLNlA3) gene. A previously reported G to A mutation causing an arginine to histidine substitution at residue 528 in the transmembrane segment IIS4 of the CACLN1A3 gene was shown in patients by restriction analysis of genomic PCR products. (J Med Genet 1995;32:44-47) Hypokalaemic periodic paralysis (HypoPP) belongs to the group offamilial periodic paralyses. These diseases are characterised by transient attacks of muscle weakness of varying duration and severity.' Changes in serum potassium concentration during the attacks constitute the basis for subdividing periodic paralysis into hypo-, hyper-, and normokalaemic forms.'
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The genetic locus ofthe normokalaemic form in unknown. Hyperkalaemic periodic paralysis (HYPP) is characterised by attacks of flaccid muscular weakness as well as myotonia, which may even be the dominant symptom. Myotonia and paralysis may also occur in separate persons within the same family.2 This association has now been solved at the genetic level: HYPP both with and without myotonia or para-myotonia,34 paramyotonia congenita,4 5 and atypical myotonia congenita6 are all known to result from mutations at various sites in the gene coding for the a unit of the adult isoform of the skeletal muscle sodium channel (SCN4A) on chromosome 1 7q.367
HypoPP (MIM 170400) is the most frequent form ofperiodic paralysis. Although it is usually transmitted as an autosomal dominant disease, sporadic cases do occur.'89 The initial attacks typically occur during the first two decades of life, sometimes increasing in frequency to weekly or even daily occurrences, but decreasing in frequency over the age of 30.10 Permanent muscular weakness on the basis of a vacuolar myopathy develops in some people and may lead to severe disability in older patients.'011 The pathophysiology of HypoPP has not been elucidated. An increased transmembrane conductance of Na'+ 1213 increased activity of the sodium potassium pump,"4 and faults in K+ conductance'516 have been proposed as the basic defect. However, even detailed neurophysiological in vitro investigations of muscle fibres have not provided an adequate explanation. 14 We were investigating the largest known Hy-poPP family'01' for linkage when the assignment of the HypoPP locus to chromosome 1 q3 1-32 was published. 15 pt in 96 well microplates as previously described23 except that end labelling of one of the primers was used for the CACNL1A3 marker. After electrophoresis, the gels were dried and exposed overnight to x ray film (Kodak X-AR).
LINKAGE ANALYSIS
Two point and multipoint lod scores were computed with the LINKAGE program package version 5.10.2627 HypoPP was considered to be autosomal dominant with a penetrance of 100%. The frequency of the gene in the general population was estimated as 0-0001.'
MUTATION SCREENING
The G to A mutation in codon 528 of the CACLN1A3 gene causes the loss of a BbvI restriction site."' Genomic DNA was amplified by PCR with the forward primer 5'-GGA-GATCCTGCTGGTGGAGTCG-3' and the reverse primer 5'-TCCTCAGGAGGCGGA- 2) were analysed in our family, resulting in convincing lod scores indicative of linkage. The maximum two point lod score (Zmax) between HypoPP and the chromosome 1q loci was 6-07 at a recombination fraction (0) of 0-00 from D1S412. The calcium channel CACNL1A3 was also linked to HypoPP: Zmax = 3 -24 at Omax = 0 -00 (table) . Multipoint analysis confirmed that the most likely location of the HypoPP gene is close to locus D1S412 (fig 3) . Haplotyping showed no recombinants between the HypoPP locus and markers DlS412, D1S413, and CACNL1A3. PCR amplification of genomic DNA was performed to screen for the recently found G to A mutation in codon 528 ofthe CACLN1A3 gene, causing loss of a BbvI restriction site. All patients showed an additional 77 bp fragment of undigested amplification product (not shown), confirming the presence of this mutation in this Dutch HypoPP family. Haplotype analysis showed several recombinants between HypoPP and D I S 158 and DM153, but not with D1S412 and the microsatellite located within the CACLN1A3 gene. Recently Jurkat-Rott et all9 found a G to A mutation in the transmembrane segment IIS4 in several independent HypoPP patients. This mutation was also found in our Dutch HypoPP family.
Discussion
This particular calcium channel is an oligomeric protein composed of two high molecular weight polypeptide subunits (ct 1 and 2) and three smaller 1, y, and 6 units.2829 The oc 1 units form the ion pore structure and also function as voltage sensors.303' The gene is mutated in the muscular dysgenesis mouse (mdg), a lethal autosomal recessive disorder in which there is a total lack of excitationcontraction coupling in homozygotes. 32 It is rather surprising to find a calcium channel gene defect implicated in the pathophysiology of HypoPP. As referred to above, most investigators have favoured other defects to explain the hypokalaemic attacks. Nevertheless, early suggestions of disturbed Ca2+ release to the contractile elements33 and an enhanced deposition of Ca 2 in the sarcoplasmatic reticulum34 already suggested an inadequate release of calcium as the underlying defect in HypoPP. Furthermore, the skeletal muscle calcium channels do play a key role in the excitation-contraction coupling.26 These findings might contribute to the understanding of the occurrence of paralysis in HypoPP. Further studies need to be performed in order to elucidate the relationship between the calcium channel defect and the drop in serum K+ concentration and the pathogenesis of permanent progressive muscle weakness.
